Top

News

  • The Work of Expanding the Editorial Board of CDR has come to a Successful Conclusion

    As of August 28, 2020, the three-month work of expanding the Editorial Board of CDR has come to a successful conclusion. A total of 30 scientists with significant international influence in the field of cancer drug resistance joined the Editor Board, with the ambition to help create a better future for CDR.
    Published on: 28 Aug 2020 Viewed: 144
  • Acknowledgment to Reviewers in 2019

    Rigorous and impartial peer-review process is very essential for success of a journal. We would like to sincerely thank each and every reviewer who dedicated his or her time and expertise to reviewing manuscripts for Cancer drug resistance in 2019.
    Published on: 3 Feb 2020 Viewed: 522
  • New Year's Blessings from Editorial Office of CDR

    New Year's Blessings from Editorial Office of CDR
    Published on: 21 Jan 2020 Viewed: 531
  • AACR 2020 Annual Meeting - We Are Coming!

    We would like to tell you that CDR, together with two sister journals JCMT and HR, will attend AACR 2020 Annual Meeting as the leading journal! Welcome to visit us at Booth #1410!
    Published on: 21 Jan 2020 Viewed: 369
  • Cancer Drug Resistance Is Now a Member of the Committee on Publication Ethics

    We are pleased to announce that the journal of Cancer Drug Resistance is Now a member of the Committee on Publication Ethics (COPE). Please see details at: https://publicationethics.org/members/cancer-drug-resistance
    Published on: 15 Mar 2019 Viewed: 1359
  • The 2018 Annual Report of Cancer Drug Resistance

    Since the first issue of CDR officially published on March 19, 2018, more and more scholars pay attention to this journal and inspired by the journal's achievement throughout the year. In 2018, CDR has totally published 20 papers of which have been cited 14 times within this year.
    Published on: 31 Jan 2019 Viewed: 1179
  • Acknowledgment to Reviewers

    We would like to sincerely thank each and every reviewer who dedicated his or her time and expertise to reviewing manuscripts for Cancer drug resistance. In the review process, at least two experts contribute comment about each paper published in CDR, without their help, we would not be as fast-growing as it is today. Thus, the Journal of Cancer Drug Resistance acknowledge with particular gratitude the following reviewers who give freely of their support during the period March 2018-December 2018.

    Published on: 17 Jan 2019 Viewed: 675
  • Special Issue eBooks

    We now offer an article collection of CDR Speical Issues to our authors, which are freely available for download on our website. If you are the Guest Editor of any of these Special Issues, please feel free to contact us for the printed version of the Ebooks. Your kind promotion of this collection through either conferences or other means would be highly appreciated.

    Published on: 16 Jan 2019 Viewed: 747